Literature DB >> 31209141

Complement in Motion: The Evolution of CD46 from a Complement Regulator to an Orchestrator of Normal Cell Physiology.

M Kathryn Liszewski1, Claudia Kemper2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31209141      PMCID： PMC7458270          DOI： 10.4049/jimmunol.1900527

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  30 in total

1.  TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity.

Authors:  Emma M Creagh; Luke A J O'Neill
Journal:  Trends Immunol       Date:  2006-06-27       Impact factor: 16.687

Review 2.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Complement-Mediated Regulation of Metabolism and Basic Cellular Processes.

Authors:  Christoph Hess; Claudia Kemper
Journal:  Immunity       Date:  2016-08-16       Impact factor: 31.745

4.  Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46.

Authors:  M Kurita-Taniguchi; A Fukui; K Hazeki; A Hirano; S Tsuji; M Matsumoto; M Watanabe; S Ueda; T Seya
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing.

Authors:  S M Russell; R L Sparrow; I F McKenzie; D F Purcell
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

6.  Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.

Authors:  J L Cole; G A Housley; T R Dykman; R P MacDermott; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.

Authors:  T W Post; M K Liszewski; E M Adams; I Tedja; E A Miller; J P Atkinson
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

Review 8.  Genomic view of the evolution of the complement system.

Authors:  Masaru Nonaka; Ayuko Kimura
Journal:  Immunogenetics       Date:  2006-08-09       Impact factor: 2.846

Review 9.  Complement regulator CD46: genetic variants and disease associations.

Authors:  M Kathryn Liszewski; John P Atkinson
Journal:  Hum Genomics       Date:  2015-06-10       Impact factor: 4.639

10.  The CD46-Jagged1 interaction is critical for human TH1 immunity.

Authors:  Gaëlle Le Friec; Devon Sheppard; Pat Whiteman; Christian M Karsten; Salley Al-Tilib Shamoun; Adam Laing; Laurence Bugeon; Margaret J Dallman; Teresa Melchionna; Chandramouli Chillakuri; Richard A Smith; Christian Drouet; Lionel Couzi; Veronique Fremeaux-Bacchi; Jörg Köhl; Simon N Waddington; James M McDonnell; Alastair Baker; Penny A Handford; Susan M Lea; Claudia Kemper
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606
View more
  14 in total

1.  Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).

Authors:  Jack R Hemsath; A Manuel Liaci; Jeffrey D Rubin; Brian J Parrett; Shao-Chia Lu; Tien V Nguyen; Mallory A Turner; Christopher Y Chen; Karolina Cupelli; Vijay S Reddy; Thilo Stehle; M Kathryn Liszewski; John P Atkinson; Michael A Barry
Journal:  J Virol       Date:  2021-11-17       Impact factor: 6.549

Review 2.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

Review 3.  Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections.

Authors:  M Kathryn Liszewski; John P Atkinson
Journal:  Curr Opin Immunol       Date:  2021-05-15       Impact factor: 7.268

Review 4.  Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease.

Authors:  Esther C W de Boer; Anouk G van Mourik; Ilse Jongerius
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

Review 5.  Complement Has Brains-Do Intracellular Complement and Immunometabolism Cooperate in Tissue Homeostasis and Behavior?

Authors:  Natalia Kunz; Claudia Kemper
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 6.  Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.

Authors:  Valentina Marchica; Federica Costa; Gaetano Donofrio; Nicola Giuliani
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 7.  Halting targeted and collateral damage to red blood cells by the complement system.

Authors:  M Jalink; E C W de Boer; D Evers; M Q Havinga; J M I Vos; S Zeerleder; M de Haas; I Jongerius
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

8.  Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.

Authors:  Valentina Marchica; Valentina Franceschi; Rosanna Vescovini; Paola Storti; Emanuela Vicario; Denise Toscani; Alessia Zorzoli; Irma Airoldi; Benedetta Dalla Palma; Nicoletta Campanini; Eugenia Martella; Cristina Mancini; Federica Costa; Gaetano Donofrio; Nicola Giuliani
Journal:  J Hematol Oncol       Date:  2020-07-11       Impact factor: 17.388

9.  Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.

Authors:  Ali S Imami; Sinead M O'Donovan; Justin F Creeden; Xiaojun Wu; Hunter Eby; Cheryl B McCullumsmith; Kerstin Uvnäs-Moberg; Robert E McCullumsmith; Elissar Andari
Journal:  Physiol Genomics       Date:  2020-08-18       Impact factor: 3.107

Review 10.  CD46 and Oncologic Interactions: Friendly Fire against Cancer.

Authors:  Michelle Elvington; M Kathryn Liszewski; John P Atkinson
Journal:  Antibodies (Basel)       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.